CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma, Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that John Knopf, Ph.D., Chief Executive Officer of Acceleron will ring The NASDAQ Stock Market Closing Bell on November 5, 2013, at 4:00 PM EST.
Help employers find you! Check out all the jobs and post your resume.
